Ubs Group Ag Aeterna Zentaris Inc. Transaction History

Ubs Group Ag

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.17 - $0.37 $631 - $1,375	-3,717 Reduced 41.72%	5,192 $1,000
Q1 2022 May 16, 2022	SELL	$0.33 - $0.42 $14,775 - $18,804	-44,773 Reduced 83.4%	8,909 $3,000
Q4 2021 Feb 14, 2022	BUY	$0.36 - $0.77 $19,316 - $41,315	53,657 Added 214628.0%	53,682 $19,000
Q3 2021 Nov 15, 2021	BUY	$0.59 - $0.88 $14 - $22	25 New	25 $0
Q2 2021 Aug 13, 2021	SELL	$0.83 - $1.14 $5,686 - $7,810	-6,851 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$0.51 - $3.34 $24,725 - $161,926	-48,481 Reduced 87.62%	6,851 $8,000
Q4 2020 Feb 11, 2021	BUY	$0.3 - $0.44 $16,599 - $24,346	55,332 New	55,332 $24,000
Q2 2020 Jul 31, 2020	SELL	$0.45 - $1.2 $876 - $2,337	-1,948 Closed	0 $0
Q1 2020 May 01, 2020	BUY	$0.42 - $1.44 $2 - $8	6 Added 0.31%	1,948 $1,000
Q4 2019 Feb 14, 2020	BUY	$0.77 - $1.08 $1,495 - $2,097	1,942 New	1,942 $2,000
Q3 2019 Nov 14, 2019	SELL	$1.0 - $2.97 $452 - $1,342	-452 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$2.04 - $5.43 $6,154 - $16,382	-3,017 Reduced 86.97%	452 $1,000
Q1 2019 May 14, 2019	BUY	$3.03 - $4.65 $7,371 - $11,313	2,433 Added 234.85%	3,469 $16,000
Q4 2018 Feb 14, 2019	SELL	$1.3 - $3.87 $16,438 - $48,936	-12,645 Reduced 92.43%	1,036 $3,000
Q3 2018 Nov 14, 2018	BUY	$1.6 - $2.03 $20,953 - $26,584	13,096 Added 2238.63%	13,681 $24,000
Q2 2018 Aug 14, 2018	BUY	$1.19 - $2.62 $696 - $1,532	585 New	585 $1,000
Q2 2017 Aug 14, 2017	SELL	N/A	-3,122 Closed	0 $0
Q1 2017 Nov 14, 2017	BUY	N/A	3,122	3,122 $9,000

Ticker AEZS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,855,880
Market Cap $19.4M
Description
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult grow...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.